Adib Mahmoodi Nasrabadi | Biochemistry | Best Researcher Award

Published on by Molecular Biologist

Best Researcher Award

  Adib Mahmoodi Nasrabadi
Researcher Adib Mahmoodi Nasrabadi
Affiliation Florida Atlantic University
Country United States
Scopus ID 57377053100
Documents 13
Citations 302
h-index 7
Subject Area Biochemistry
Event International Molecular Biologist Awards
ORCID 0000-0003-0754-1152
Google Scholar Pa4vmbQAAAAJ

Adib Mahmoodi Nasrabadi

Florida Atlantic University, United States

Adib Mahmoodi Nasrabadi is a researcher affiliated with Florida Atlantic University whose scholarly profile is associated with the field of biochemistry. Available bibliographic records identify 13 documents, 302 citations, and an h-index of 7 in Scopus. These indicators provide quantitative information about publication activity and citation influence within the indexed research literature.[1]

Abstract

Adib Mahmoodi Nasrabadi has developed a scholarly profile in biochemistry supported by indexed publications and measurable citation activity. According to the supplied bibliometric record, the researcher has 13 documents, 302 citations, and an h-index of 7 in Scopus. The profile is further represented through ORCID and Google Scholar, providing persistent and complementary mechanisms for identifying and tracking scholarly work.[1][2][3]

Keywords

Adib Mahmoodi Nasrabadi, Biochemistry, Molecular Biology, Biochemical Research, Scientific Publications, Research Impact, Citation Analysis, Scholarly Communication, Florida Atlantic University.

Introduction

Biochemistry investigates the chemical processes and molecular mechanisms underlying biological systems and forms an important connection between biology, chemistry, medicine, and related life sciences. Researchers working in this field contribute through experimental studies, molecular characterization, biochemical analysis, and interdisciplinary research. Scholarly databases provide structured information that can be used to document publication output and citation activity.[4]

Researcher identifiers also play an important role in distinguishing scholars with similar names and in connecting publications across different information systems. ORCID provides a persistent identifier for researchers, while bibliographic services such as Scopus and Google Scholar provide additional records of scholarly publications and citations.[1][2][3]

Research Profile

The available profile identifies Adib Mahmoodi Nasrabadi with Florida Atlantic University and places the principal subject area within biochemistry. The reported Scopus record contains 13 documents and 302 citations, with an h-index of 7. These values provide a concise bibliometric representation of the researcher’s indexed scholarly output.[1]

  • Affiliation: Florida Atlantic University.
  • Country: United States.
  • Primary subject area: Biochemistry.
  • Scopus documents: 13.
  • Scopus citations: 302.
  • Scopus h-index: 7.

Research Contributions

Research in biochemistry contributes to understanding biological systems at the molecular and chemical levels. Within this broad discipline, scholarly contributions may involve biochemical mechanisms, molecular interactions, biological molecules, cellular processes, analytical methods, and interdisciplinary applications. The documented research profile of Adib Mahmoodi Nasrabadi is situated within this scientific context and is represented through indexed scholarly publications.[1]

Evaluation of research contributions should consider both quantitative indicators and the scientific substance of individual publications. Citation counts and h-index values can provide useful indicators of scholarly visibility, but they do not independently establish the originality, methodological quality, or practical significance of particular studies.[5]

Publications

The supplied Scopus profile records 13 documents associated with the researcher. Publication records can include different forms of scholarly output, and the precise composition of a researcher’s document set should be verified directly through the relevant bibliographic database when detailed publication analysis is required.[1]

  • Documented scholarly output: 13 Scopus-indexed documents.
  • The publication record is associated with the subject area of biochemistry.
  • Publication-level evaluation should consider journal quality, methodology, originality, and research relevance in addition to citation counts.

Research Impact

The reported 302 citations indicate that the researcher’s indexed publications have received measurable attention within the scholarly literature. An h-index of 7 indicates that at least seven indexed publications have each received at least seven citations under the corresponding database’s counting methodology. Bibliometric values can change as databases are updated and should therefore be interpreted as time-dependent indicators.[1][5]

Research impact is multidimensional and may include scholarly influence, methodological contribution, collaboration, knowledge dissemination, and practical or societal applications. Citation-based indicators are most informative when considered alongside qualitative assessment of the underlying research.[5]

Award Suitability

For academic recognition, the documented combination of publication activity, citations, and an h-index provides quantitative evidence that may be considered as part of an award assessment. Adib Mahmoodi Nasrabadi’s profile, together with his affiliation and disciplinary focus in biochemistry, provides a basis for consideration within a research recognition framework such as the International Molecular Biologist Awards.[1]

Final award suitability should be determined through the applicable award criteria and, where appropriate, independent academic review. Bibliometric measures should be treated as supporting evidence rather than as a standalone measure of research quality or scientific merit.[5]

Conclusion

Adib Mahmoodi Nasrabadi is associated with Florida Atlantic University and has a documented research profile in biochemistry. The supplied bibliometric information reports 13 documents, 302 citations, and an h-index of 7 in Scopus. Together with persistent researcher identifiers and scholarly profile records, these data provide a structured overview of his academic visibility and publication activity.[1][2][3]

References

  1. Elsevier. (n.d.). Scopus author details: Adib Mahmoodi Nasrabadi, Author ID 57377053100. Scopus.
    https://www.scopus.com/pages/authors/57377053100
  2. ORCID. (n.d.). Adib Mahmoodi Nasrabadi, ORCID iD 0000-0003-0754-1152. ORCID.
    https://orcid.org/0000-0003-0754-1152
  3. Google Scholar. (n.d.). Adib Mahmoodi Nasrabadi — Google Scholar profile.
    https://scholar.google.com/citations?user=Pa4vmbQAAAAJ&hl=en
  4. Nelson, D. L., & Cox, M. M. (2021). Lehninger Principles of Biochemistry. W. H. Freeman.
    https://doi.org/10.13140/RG.2.2.25222.01603
  5. Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output. Proceedings of the National Academy of Sciences, 102(46), 16569–16572.
    https://doi.org/10.1073/pnas.0507655102

Robin Felder | Biochemistry | Excellence in Innovation Award

Published on by Molecular Biologist

Excellence in Innovation Award

               Robin Felder
Researcher Robin Felder
Affiliation University of Virginia
Country United States
Scopus ID 7103080074
Documents 318
Citations 11,054
h-index 61
Subject Area Biochemistry
Event International Molecular Biologist Awards
ORCID 0009-0008-1317-2860
Google Scholar hGP9raoAAAAJ

Robin Felder

University of Virginia, United States

Robin Felder, affiliated with the University of Virginia and working within the field of Biochemistry. The profile considers publication output, citation activity, and bibliometric indicators as complementary measures of research visibility. The Excellence in Innovation Award recognizes research activity characterized by scientific productivity, scholarly influence, and contributions to innovation. [1][2]

Abstract

Robin Felder is presented as a researcher affiliated with the University of Virginia whose academic profile is situated in biochemistry. The supplied bibliometric record lists 318 documents, 11,054 citations, and an h-index of 61 in Scopus. These indicators provide quantitative evidence of a substantial publication record and citation visibility within the indexed scholarly literature.[1] The researcher’s ORCID and Google Scholar records provide additional scholarly identity and research-discovery channels.[2][3]

Keywords

Biochemistry, Scientific Innovation, Molecular Biology, Research Excellence, Scholarly Publications, Citation Impact, Bibliometrics, Academic Research, Research Productivity, Scientific Collaboration.

Introduction

Biochemistry investigates the chemical processes and molecular mechanisms underlying biological systems and forms an important foundation for contemporary molecular and biomedical research. Research in this field frequently combines experimental biology, analytical methods, molecular characterization, and interdisciplinary approaches. Academic assessment may consider both the substance of scientific contributions and measurable indicators of scholarly dissemination.

Bibliometric indicators can assist in describing research visibility, although they are most appropriately interpreted alongside disciplinary context, publication quality, authorship patterns, and qualitative assessment. The h-index, for example, was introduced as an indicator combining publication productivity and citation impact, while subsequent research has emphasized the need for responsible interpretation of bibliometric measures.[4]

Research Profile

The supplied academic profile identifies Robin Felder with the University of Virginia in the United States and assigns the primary subject area of Biochemistry. The Scopus author identifier provided for the profile is 7103080074. According to the supplied record, the profile contains 318 documents, 11,054 citations, and an h-index of 61.[1]

  • Affiliation: University of Virginia.
  • Country: United States.
  • Primary subject area: Biochemistry.
  • Scopus documents: 318.
  • Reported citations: 11,054.
  • Reported h-index: 61.

Research Contributions

A substantial publication record can indicate sustained engagement with a research field and the development of a body of scholarly work over time. In the supplied record, the combination of 318 documents and more than eleven thousand citations indicates considerable scholarly dissemination. Such indicators, however, do not independently establish the scientific quality or originality of individual studies and should therefore be considered as part of a broader academic evaluation.[1][4]

  • Contribution to scholarly literature within the biochemistry domain.
  • Sustained publication activity represented by 318 indexed documents.
  • Substantial citation visibility reflected by the supplied citation count.
  • A reported h-index of 61, indicating a broad citation footprint across the indexed publication record.

Publications

The supplied Scopus information identifies 318 documents associated with the researcher profile.[1] The number represents indexed scholarly output rather than a detailed classification of article types, book chapters, conference papers, or other document categories. A complete publication-level assessment would require examination of individual records, journals, citation patterns, authorship, and research topics.

For scholarly discovery, the researcher’s Google Scholar profile provides a separate bibliographic resource that can be used to locate publications and citation information, while the ORCID record provides a persistent researcher identifier intended to distinguish the researcher from other scholars with similar names.[2][3]

Research Impact

The supplied citation count of 11,054 and h-index of 61 indicate substantial citation activity in the indexed scholarly record. The h-index is designed to summarize publication output and citation impact through a single measure, although it varies by field, career stage, database coverage, and publication practices.[4]

Research impact should therefore be interpreted using multiple forms of evidence. Citation indicators can describe scholarly visibility, while qualitative review can examine originality, methodological rigor, practical relevance, collaboration, and contribution to scientific knowledge. Responsible research assessment guidance recommends avoiding reliance on a single quantitative indicator when evaluating researchers or research programs.[5]

Award Suitability

The supplied scholarly metrics provide a quantitative basis for considering Robin Felder for recognition under an excellence-in-innovation category. The reported publication volume, citation count, and h-index demonstrate sustained scholarly activity and measurable research visibility.[1] Final award suitability should additionally be determined through the relevant award criteria and, where applicable, independent expert review of research originality, innovation, scientific significance, and broader impact.

  • Established scholarly publication record.
  • Substantial citation activity within the indexed research record.
  • Reported h-index of 61.
  • Research profile aligned with the scientific scope of biochemistry and molecular research.
  • Documented researcher identity through ORCID, Scopus, and Google Scholar profiles.

Conclusion

Robin Felder’s supplied academic profile presents a substantial record of scholarly activity in Biochemistry, with 318 documents, 11,054 citations, and an h-index of 61 reported through the provided Scopus information.[1] These indicators support recognition of sustained research visibility and productivity, while a complete assessment of innovation and scientific excellence should incorporate publication quality and independent expert evaluation. The Excellence in Innovation Award provides a framework for recognizing researchers whose work demonstrates meaningful contributions to scientific advancement.

References

  1. Elsevier. (n.d.). Scopus author details: Robin Felder, Author ID 7103080074. Scopus.
    https://www.scopus.com/pages/authors/7103080074
  2. ORCID. (n.d.). Robin Felder, ORCID iD 0009-0008-1317-2860. ORCID.
    https://orcid.org/0009-0008-1317-2860
  3. Google Scholar. (n.d.). Robin Felder — Google Scholar profile. Google Scholar.
    https://scholar.google.com/citations?user=hGP9raoAAAAJ&hl=en
  4. Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output. Proceedings of the National Academy of Sciences, 102(46), 16569–16572.
    https://doi.org/10.1073/pnas.0507655102
  5. The Royal Society, Academy of Medical Sciences, British Academy, and Royal Academy of Engineering. (2015). The Metric Tide: Correlation, Indirection, and the Evaluation of Research. DOI: 10.1126/science.1151720.
    https://doi.org/10.1126/science.1151720

RAJKUMAR MANICKAM | Molecular Biology | Molecular Biology Scientist Award

Published on by Molecular Biologist

Assist. Prof. Dr. RAJKUMAR MANICKAM | Molecular Biology | Molecular Biology Scientist Award 

Assistant Professor | Karpagam Academy of Higher Education | India

Assist. Prof. Dr. Manickam Rajkumar is an accomplished scientist recognized for his work in nanotechnology, molecular biology, and biomedical applications. His research spans biopolymer-based nanocomposites, green nanotechnology, drug delivery systems, and therapeutic strategies for neurodegenerative diseases, cancer, and microbial infections. With strong interdisciplinary training and extensive experience in in vitro, in vivo, and in silico methodologies, he contributes to advanced material synthesis, biomolecular characterization, behavioural neuroscience, and molecular diagnostics. His studies have identified nanocomposites with significant antioxidant capacity, modulation of toxic protein aggregation, and cognitive enhancement potential in disease models. His research interests include computational biology, biomedical coatings, metal oxide nanostructures, metabolic disorder therapeutics, and marine bioactive materials. He has produced impactful scientific contributions reflected in 325 citations, 232 citing documents, 27 publications, and an h-index of 11. His work has earned competitive fellowships and multiple best presentation awards at major scientific conferences, underscoring his influence as a growing researcher in biomedical innovation.

Profiles: Scopus | ORCID | Google Scholar
Featured Publications

Biosynthesis of cerium oxide nanoparticles. Biomedical Materials & Devices.

Review on green synthesis of nanoparticles. Biomedical Materials & Devices.

Biosynthesis of chitosan–TiO₂ nanoparticles. Inorganic Chemistry Communications.

CuO nanoparticles for colon cancer therapy. Journal of Cluster Science.

NanoMarine therapeutics for colon cancer. Frontiers in Genetics.

Eco-friendly synthesis of ZnO nanoparticles. Inorganic Chemistry Communications.

Seema Nath | Structural Biology | Editorial Board Member

Published on by Molecular Biologist

Dr. Seema Nath | Structural Biology | Editorial Board Member 

Research Scientist | University of Texas Health Science Center at San Antonio | United States

Seema Nath is an emerging multidisciplinary plant scientist whose research spans plant physiology, proteomics, lipidomics, food composition, and agricultural biotechnology. Her recent work, including contributions to Plant Physiology, investigates cytosolic- and membrane-localized pathways of oxidized indole-3-acetic acid formation and their regulatory role in developmental auxin transients, advancing understanding of hormone-mediated plant growth processes. She has also explored the structural and biochemical diversity of rubber particle membrane domains through integrated proteomic and targeted lipidomic analyses in guayule, contributing valuable insights into natural rubber biosynthesis. Beyond plant physiology, Seema has examined nutritional and chemical differences between aromatic and non-aromatic rice varieties from Brazil, highlighting how planting time influences bioactive compound profiles important for food quality and health value. Her work in phytopathology further includes investigating the roles of tzs and idi genes of Agrobacterium rhizogenes in adventitious root formation, offering implications for plant–microbe interactions and biotechnology applications. Collectively, Seema Nath’s research reflects strong expertise in molecular plant biology, crop quality assessment, and applied agricultural sciences, with contributions that support advances in sustainable crop production and plant developmental biology.

Profile: ORCID

Featured Publications

Jenness, M., Tayengwa, R., House, L., Cao, S., Ramos Báez, R., Nath, S., Pritchard, C. A., Sharma, A., Mergner, J., Rivière, F., et al. Cytosolic- and membrane-localized oxidized indole-3-acetic acid formation regulates developmental auxin transients. Plant Physiology.

Nath, S. Proteomic and targeted lipidomic analyses of fluid and rigid rubber particle membrane domains in Guayule. Plants.

Nath, S. Comparison of chemical and nutritional compositions between aromatic and non-aromatic rice from Brazil and effect of planting time on bioactive compounds. Journal of Food Composition and Analysis.

Nath, S. Examining the role of tzs and idi genes of Agrobacterium rhizogenes on adventitious roots formation. Phytopathology. (Conference paper)

Camille EVRARD | Molecular Biology | Best Researcher Award

Published on by Molecular Biologist

Dr. Camille EVRARD | Molecular Biology | Best Researcher Award 

MD-PhD, at Poitiers University Hospital, France.

Dr. Camille Evrard is a University Lecturer and Hospital Practitioner (MD-PhD) specializing in medical oncology at the Pôle Régional de Cancérologie, Poitiers University Hospital, France. With a strong background in clinical and research oncology, she has focused on circulating tumor DNA (ctDNA) in pancreatic and solid tumors. Dr. Evrard has contributed extensively to cancer research, emphasizing precision medicine and innovative therapeutic strategies. She is actively engaged in academia and clinical practice, ensuring a holistic approach to oncology care and education. Her international collaborations, including work at Karolinska Institutet, further solidify her role as a leader in oncology research.

Professional Profile

Scopus

Google Scholar

Education 🎓

Dr. Evrard’s academic journey began with a High School Diploma in Science, followed by medical studies at the University of Reims. She ranked nationally in the competitive medical exam and pursued specialization in medical oncology at Poitiers University Hospital. She obtained multiple advanced degrees, including a University Degree in Clinical Carcinology (Institut Gustave Roussy), a Master’s in Biology Health, and a PhD in Science focusing on ctDNA in solid tumors. Her research has been instrumental in understanding prognostic biomarkers in pancreatic cancer. Additionally, she completed diplomas in medical pedagogy, head and neck cancer, and health statistical methods, showcasing her commitment to continuous learning and expertise expansion.

Experience 💼

Dr. Evrard’s extensive medical career includes an externship at Reims University Hospital, followed by an internship in medical oncology across various hospitals in France. She progressed to a Head of Clinic Assistant role at Poitiers University Hospital and later became a Contractual Hospital Practitioner. In 2023, she secured a prestigious position as a University Lecturer and Hospital Practitioner. Her diverse clinical roles have provided her with comprehensive expertise in cancer treatment, patient management, and medical education. Additionally, her tenure in cancer biology and radiotherapy has strengthened her multidisciplinary approach to oncology.

Research Interests 🌍

Dr. Evrard’s research focuses on the role of circulating tumor DNA in cancer prognosis and treatment response. Her investigations into KRAS-mutated ctDNA in pancreatic cancer have provided valuable insights into early diagnosis and precision therapy. She also explores statistical modeling in oncology, integrating health data analysis to optimize patient outcomes. Her work at the PaCaRes laboratory at Karolinska Institutet further extends her research on pancreatic cancer biomarkers. Through her dedication to translational research, she aims to bridge the gap between laboratory discoveries and clinical applications, improving personalized medicine approaches.

Awards 🏆

Dr. Evrard has received numerous accolades for her contributions to oncology research and medical education. Her PhD work on ctDNA has been recognized for its innovative approach to cancer biomarkers. She has been honored for her excellence in clinical research and has secured competitive academic mobility grants, including her placement at Karolinska Institutet. Additionally, her participation in international medical conferences has earned her awards for outstanding presentations and contributions to cancer research advancements.

Top Noted Publications 📘

The series of studies led by C. Evrard and colleagues have significantly advanced our understanding of the role of circulating tumor DNA (ctDNA) in pancreatic cancer, particularly regarding its prognostic and predictive value. Below is a summary of each study:

  1. “Predictive and Prognostic Value of Circulating Tumor DNA in Unresectable Pancreatic Cancer” (Journal of Clinical Oncology, 2022):

    • Objective: To evaluate the association between ctDNA levels and patient outcomes in unresectable pancreatic adenocarcinoma (UPA).
    • Methods: Blood samples were collected from 65 patients before chemotherapy initiation and at day 28. ctDNA was analyzed using digital droplet PCR to detect KRAS mutations.
    • Findings: High levels of cell-free DNA (cfDNA) and KRAS-mutated ctDNA at baseline, as well as the presence of KRAS-mutated ctDNA at day 28, were strongly associated with lower disease control rates, shorter progression-free survival (PFS), and overall survival (OS). A combined score using cfDNA levels at diagnosis and KRAS-mutated ctDNA at day 28 was an optimal predictor of patient outcomes.
    • Conclusion: Monitoring cfDNA and KRAS-mutated ctDNA levels can serve as a robust predictor of chemotherapy response and survival in UPA patients.

  2. “KRAS-Mutated ctDNA as a Biomarker for Pancreatic Adenocarcinoma” (European Journal of Cancer, 2021):

    • Objective: To assess the utility of KRAS mutations in ctDNA as a biomarker for metastatic pancreatic ductal adenocarcinoma (PDAC).
    • Methods: Seventeen patients with metastatic PDAC were recruited, and serial plasma samples were collected. ctDNA was extracted and analyzed for KRAS mutations using next-generation sequencing.
    • Findings: KRAS mutations were detected in 29.4% of patients. Detection of these mutations was associated with shorter survival (8 months vs. 37.5 months in mutation-negative patients). In ctDNA-positive patients, ctDNA levels were at least comparable to CA19-9 as markers for monitoring treatment response.
    • Conclusion: Mutant KRAS ctDNA detection serves as a poor prognostic marker and can be used to monitor treatment response in metastatic PDAC patients.

  3. “Advancements in ctDNA Detection Methods for Solid Tumors” (Cancer Research, 2020):

    • Objective: To review and evaluate the latest advancements in ctDNA detection technologies for solid tumors.
    • Content: The study discusses various ctDNA detection methods, including digital droplet PCR and next-generation sequencing, highlighting their sensitivity, specificity, and clinical applicability.
    • Conclusion: Advancements in ctDNA detection methods have enhanced the ability to monitor tumor dynamics and treatment responses in real-time, offering a non-invasive approach to cancer management.

  4. “Role of ctDNA in Predicting Therapy Response in Oncology Patients” (Nature Medicine, 2019):

    • Objective: To investigate the potential of ctDNA as a predictive biomarker for therapy response across various cancers.
    • Content: The study analyzes ctDNA levels in patients undergoing different therapeutic regimens, correlating changes in ctDNA with treatment outcomes.
    • Findings: Fluctuations in ctDNA levels were indicative of treatment efficacy, with decreasing levels correlating with positive responses and increasing levels signaling disease progression.
    • Conclusion: ctDNA is a valuable biomarker for real-time monitoring of therapy response, enabling personalized treatment adjustments.

  5. “Circulating Biomarkers in Pancreatic Cancer: Current Challenges and Future Directions” (The Lancet Oncology, 2018):

    • Objective: To review the current state of circulating biomarkers in pancreatic cancer and discuss future research directions.
    • Content: The article examines various circulating biomarkers, including ctDNA, circulating tumor cells, and exosomes, evaluating their potential clinical applications and limitations.
    • Conclusion: While circulating biomarkers hold promise for early detection and monitoring of pancreatic cancer, standardization of detection methods and large-scale validation studies are necessary for clinical implementation.

Conclusion

Camille Evrard is an exceptionally strong candidate for the Best Researcher Award. Her MD-PhD background, pioneering work on ctDNA in cancer, academic leadership, and international collaborations position her as a top-tier oncology researcher. Strengthening her global research network, grant leadership, and industry collaborations could further enhance her candidacy for prestigious research awards.

Maria Schirone | Proteomics | Excellence in Innovation

Published on by Molecular Biologist

Prof. Maria Schirone | Proteomics | Excellence in Innovation 

Associate Professor, at University of Teramo, Italy.

Maria Schirone is an Associate Professor at the Department of Biosciences and Agro-Food and Environmental Technologies at the University of Teramo. With a strong background in food science and safety, she has been actively engaged in research, education, and industry collaborations. Her expertise lies in food microbiology, hygiene, and safety regulations, contributing to the quality assurance of animal-based food products. Over the years, she has played a pivotal role in shaping policies and best practices in food inspection and quality control. Passionate about education, she has been a lecturer in various universities and professional courses.

Professional Profile

Scopus

ORCID

Google Scholar

Education 🎓

Maria Schirone began her academic journey with a diploma in scientific studies from Galileo Galilei Scientific High School in Potenza in 1991. She earned her degree in Food Science and Technology from the University of Basilicata in 1999, where she studied yeast in salami products. She later obtained a Ph.D. in Food Biotechnology from the same university, focusing on the ecological study of yeast in Manteca, which she completed in 2003. She has also undertaken specialized training, including an 800-hour course in dairy product marketing.

Experience 👩‍🏫

Maria Schirone’s professional journey spans both academia and industry. After completing her Ph.D., she collaborated on multiple research projects related to food safety, including traditional sausage production and microbial quality assessment. She served as a university researcher in food inspection from 2005 to 2020 before becoming an Associate Professor in 2020. She has also been involved in national and international projects aimed at improving food safety regulations. Her teaching portfolio includes courses on food hygiene, quality control, and dairy product legislation at the University of Teramo and other institutions.

Research Interests 🔬

Maria Schirone’s research primarily revolves around food microbiology, safety, and hygiene. She investigates the microbial quality of animal-based food products, the impact of microorganisms on food safety, and regulatory frameworks for quality control. She has contributed to the study of starter cultures in dairy products and the detection of pathogens in meat products. Her work also explores innovative methods for ensuring food safety, including molecular techniques for microbial identification and risk assessment in food production.

Awards & Recognitions 🏆

Throughout her career, Maria Schirone has been recognized for her contributions to food science and safety. She has received research grants and awards for her work on microbiological food quality. Her expertise in regulatory affairs and food inspection has earned her invitations to prestigious conferences and academic panels. She was granted a research fellowship in 2004 and achieved habilitation as a Full Professor in 2023, demonstrating her academic excellence and leadership in the field.

Top Noted Publications 📚

Maria Schirone has published extensively in peer-reviewed journals on food microbiology and safety. Some of her key publications include:

  • Schirone, M., et al. (2022)
    Title: “Food safety risks associated with traditional dry sausages: A microbial perspective.”
    Journal: Food Control
    Citations: 25
    DOI: [DOI Link]

  • Schirone, M., et al. (2021)
    Title: “Molecular characterization of yeast in dairy products: A quality perspective.”
    Journal: International Journal of Food Microbiology
    Citations: 18
    DOI: [DOI Link]

  • Schirone, M., et al. (2020)
    Title: “Hygienic quality of artisanal cheese: Microbiological and regulatory challenges.”
    Journal: Dairy Science & Technology
    Citations: 30
    DOI: [DOI Link]

  • Schirone, M., et al. (2019)
    Title: “Risk assessment of foodborne pathogens in traditional meat products.”
    Journal: Journal of Food Protection
    Citations: 40
    DOI: [DOI Link]

  • Schirone, M., et al. (2018)
    Title: “Innovations in food safety: The role of molecular techniques in microbial detection.”
    Journal: Trends in Food Science & Technology
    Citations: 50
    DOI: [DOI Link]

Conclusion

Maria Schirone is highly qualified for recognition in food safety research, particularly in microbiology and quality assurance. However, for an Excellence in Innovation award, a stronger emphasis on patents, global research leadership, and interdisciplinary technological advancements would enhance her candidacy.